Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enhanced CCL2-CCR2 signalling promotes recruitment of monocyte-derived macrophages in progressive fibrosing hypersensitivity pneumonitis.

Respiratory research·2026
Same author

Non-invasive environmental DNA sampling reveals tuberculosis risks at the human - Great Ape Interface in Africa.

Emerging microbes & infections·2026
Same author

Upper Gastrointestinal Bleeding Due to Ruptured Gastric Varices: A Diagnostic Challenge.

Cureus·2026
Same author

Role of Coronary Artery Calcium Score CT in Risk Stratification of Asymptomatic Individuals.

Journal of cardiovascular development and disease·2025
Same author

The conquest of the north continues: <i>Baylisascaris procyonis</i> in free-ranging invasive raccoons (<i>Procyon lotor</i>) from Germany, including a first report in the northeastern state of Mecklenburg-Western Pomerania.

International journal for parasitology. Parasites and wildlife·2025
Same author

The Trans-Kingdom Spectrum of Mpox-like Lesion Pustules of Suspect Patients in the Mpox Clade Ib Outbreak in Eastern Democratic Republic of the Congo.

Microorganisms·2025

Related Experiment Video

Updated: Jun 12, 2026

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

Adjunctive micronutrient supplementation for pulmonary tuberculosis.

Rodrigo X Armijos1, M Margaret Weigel, Rocío Chacon

  • 1Department of Health Promotion/MPH Program, College of Health Sciences, University of Texas, El Paso, TX 79902-0581, USA. rxarmijos@utep.edu

Salud Publica De Mexico
|May 21, 2010
PubMed
Summary
This summary is machine-generated.

Micronutrient supplementation, including zinc and vitamin A, improved tuberculosis treatment outcomes by accelerating sputum smear conversion. This suggests enhanced immune response and faster elimination of bacilli in patients.

Related Experiment Videos

Last Updated: Jun 12, 2026

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

Area of Science:

  • Immunology
  • Nutritional Science
  • Infectious Disease Research

Background:

  • Tuberculosis (TB) remains a significant global health challenge.
  • Optimizing treatment outcomes for TB patients is crucial.
  • Micronutrient deficiencies can impact immune function and disease progression.

Purpose of the Study:

  • To evaluate the impact of zinc and vitamin A supplementation on tuberculosis patient outcomes.
  • To assess the effect of micronutrients on sputum smear conversion rates.
  • To investigate the influence of supplementation on immune markers in TB patients.

Main Methods:

  • A randomized, double-blinded, placebo-controlled trial involving pulmonary TB patients.
  • Patients received zinc and vitamin A supplements or placebo for four months.
  • Measurements included dietary intake, blood micronutrient levels, immune response (cytokine mRNA), and sputum smear conversion.

Main Results:

  • Micronutrient supplementation significantly increased the proportion of patients with negative sputum smears by month 3 compared to placebo (p=0.03).
  • Supplementation led to increased TNF-alpha and IFN-gamma, and decreased IL-10 at month 2.
  • Micronutrient supplementation appeared to accelerate the therapeutic effects of standard TB chemotherapy.

Conclusions:

  • Earlier elimination of Mycobacterium tuberculosis bacilli from sputum was linked to improved zinc status and Th1 immune response.
  • Micronutrient supplementation, particularly zinc, may enhance TB treatment efficacy.
  • The therapeutic benefit of vitamin A supplementation was less pronounced in this study.